# The Influence of Seasonal Variations in Clinical Trials Based on Gut Microbiota Studies

## TL;DR

This paper reviews how seasonal changes affect gut microbiota and highlights the importance of considering seasonality in clinical trials.

## Contribution

The paper introduces the need to account for seasonal variations in gut microbiota studies to improve clinical trial accuracy.

## Key findings

- Seasonal changes in diet and environment significantly alter gut microbiota composition.
- Ignoring seasonality in clinical trials may bias results and therapeutic efficacy assessments.
- Seasonal variations in gut microbiota could influence the progression of chronic diseases.

## Abstract

Seasonality is a key determinant in shaping the composition and function of the human gut microbiota, exerting its influence through multiple interconnected factors. These include seasonal variations in diet, environmental conditions (such as temperature, humidity, and sunlight exposure), behavioral patterns (physical activity, time spent outdoors), and the incidence of seasonal infections. These changes are most visible in certain populations where food availability follows a seasonal pattern. Increasing evidence suggests that gut microbiota composition undergoes seasonal variations, which may have significant implications for human health. In patients with non-communicable chronic diseases (NCDs), where microbiota dysbiosis plays a crucial role in disease progression, understanding the seasonal effects on gut microbiota is essential. These dynamic changes impact the gut microbiota immune system interaction and may contribute to the onset or exacerbation of various diseases, including chronic inflammatory, metabolic, and autoimmune disorders. Most clinical trials on probiotics do not consider seasonality as a confounding variable, which could impact the interpretation of results and therapeutic efficacy, potentially biasing estimates of intervention efficacy or associations with disease. This review examines the current evidence on gut microbiota seasonality, discusses its potential bias, and outlines methodological considerations for future clinical trials.